Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05527652 · ClinicalTrials.gov registry record · NA

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

A NA study of Obstructive Sleep Apnea and Down Syndrome, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05527652 is a NA study of Obstructive Sleep Apnea and Down Syndrome that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05527652, a NA study of Obstructive Sleep Apnea and Down Syndrome, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

Interventions

  • DEVICE Self-Supporting Nasopharyngeal Airway (ssNPA)

Study Locations (1)

Michigan

  • The University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-11-16
Est. Completion 2026-12
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05527652

The ClinicalTrials.gov registry entry for NCT05527652 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (82% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Self-Supporting Nasopharyngeal Airway (ssNPA) is the first listed.

NCT05527652 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05527652 about?

NCT05527652 is a clinical study titled "Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia". The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

What is the current status of trial NCT05527652?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-11-16. Estimated completion is 2026-12.

What conditions does trial NCT05527652 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Down Syndrome, Tolerance, Trisomy 21, Nasal Airway Obstruction.

What interventions are being tested in trial NCT05527652?

The interventions under investigation include: Self-Supporting Nasopharyngeal Airway (ssNPA) (DEVICE).

Who is sponsoring clinical trial NCT05527652?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05527652 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.